Chugai Pharmaceutical Co (FRA:CUP) Net Income (Discontinued Operations) : €0 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Chugai Pharmaceutical Co Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. Chugai Pharmaceutical Co's Net Income (Discontinued Operations) for the three months ended in Jun. 2024 was €0 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was €0 Mil.

Chugai Pharmaceutical Co Net Income (Discontinued Operations) Historical Data

The historical data trend for Chugai Pharmaceutical Co's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Net Income (Discontinued Operations) Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Discontinued Operations)

Get a 7-Day Free Trial

Chugai Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Income (Discontinued Operations)	Get a 7-Day Free Trial															-	-	-	-	-

Chugai Pharmaceutical Co Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Chugai Pharmaceutical Co Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (FRA:CUP) » Definitions » Net Income (Discontinued Operations)

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA 4519:Japan CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.

Chugai Pharmaceutical Co Headlines

No Headlines